What Pharma Needs Next is a podcast for commercial and medical leaders. You’ll hear from life sciences experts on the trends re-shaping biopharma, how technology and data are accelerating their vital work, and ways to improve customer-centricity in the face of HCP and KOL access challenges.
Michael Hamann and Andreas Gerloff join Christoph Bug to examine key enablers of medical impact. Discover how MSD and Daiichi Sankyo Europe use AI to analyze MSL insights, personalize education, and measure relationship trust across an evolving healthcare ecosystem to improve patient outcomes.
3 Jul 2026
AI-driven insights through connected data and software
In this episode, Stefan Schmidt and Florian Schnappauf discuss key technology shifts from Cloud to AI, and the accelerated pace of commercial innovation. Explore how Bayer is moving from a system of record to a system of insights with Vault CRM and a connected, unified data infrastructure, powered by Veeva Data Cloud. Schmidt emphasizes the importance of data quality and harmonization for AI success and envisions a future where AI removes administrative burdens to allow field teams to focus on valuable customer interactions.
16 Apr 2026
Architecting the AI-Ready Enterprise
In this episode, Kieron Scrutton joins Florian Schnappauf to discuss architecting an AI-ready enterprise to achieve commercial efficiency at scale. Discover why prioritizing speed and a zero-disruption allowed GSK to move quickly to a next-generation platform with AI embedded to support its ambition of impacting 2.5 billion patients by 2030. Kieron shares how to identify high-value business processes for AI investment and the importance of role-specific training and data-driven decisions.
6 Oct 2025
UCB and Takeda: Improving the Customer Experience through Medical-Commercial Collaboration
What happens when medical and commercial teams truly align? Stronger launches, a smoother HCP experience, and better patient outcomes. In this episode, Christoph Bug speaks with Pascal Vande Gucht of UCB and Georgios Tramountanis of Takeda about breaking down silos and creating unified, cross-functional strategies. They explore how visibility, shared messaging, and thoughtful change management fuel collaboration–and how tools like GenAI and data platforms are driving the next wave of transformation.
4 Jun 2025
Turning Content into Memorable Customer Experiences
How does great content become memorable customer experiences in life sciences? Erica Taylor and Oz Demir of Genentech share their recent experiences of spearheading marketing transformation, including success factors as you get started and how to think about behavioral change. They explain the novel ways their teams are using data and automation to deliver on business goals to quickly scale personalized content for customers.
29 Nov 2024
Preparing for a Faster Trial-to-Treatment Pathway
Pharmaphorum’s Nicole Raleigh interviews Chris Moore, president of Veeva Europe, on trends shaping commercial life sciences. Chris highlights AI’s potential use cases, the need for caution, and how commercial and medical leaders are overcoming access challenges to accelerate treatment pathways.
29 Nov 2024
Preparing for a Launch: Pharma's High-Stakes Gamble
Veeva's Florian Schnappauf speaks to Andy Eeckhout of ADVANZ PHARMA about ensuring launch success. Preparing for a launch is a high-stakes gamble for all biopharma companies, particularly those focused on rare diseases. Andy explains how ADVANZ uses data to prepare for a launch, scale across multiple markets, and help MSLs get up-to-speed quickly for an in-depth scientific discussion with experts.
29 Nov 2024
The Problem of Plenty in Life Sciences
Despite major advances in recent years, it is still too difficult for biopharma field teams to bring together all relevant information to serve HCPs. Florian Schnappauf and Rakesh Vashishta discuss whether the industry asks too much of its field teams, how we can avoid drowning in data, and the changing role of reps to orchestrators of the customer experience.
29 Nov 2024
Navigating the New Medical Affairs Landscape: Data, Impact, and the Evolving MSL Role
In this episode, Christoph Bug, VP Global Medical at Veeva, discusses the evolving role of medical affairs with industry experts. They explore how medical teams adapt to the growing demand for scientific exchange and how medical affairs can become a more strategic, data-driven decision-making organization.
13 May 2024
Navigating the New Medical Affairs Landscape
As the clinical landscape evolves, healthcare professionals are constantly navigating more complex data, and putting a greater demand on medical affairs for more scientific exchange.
The increasing visibility not only puts additional pressure on medical teams to be operationally effective but also to better demonstrate outcomes.
In this episode, Christoph Bug, VP Global Medical at Veeva, speaks to several industry experts about the ongoing transformation of medical affairs to become a more strategic, data-driven decision-making organization.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
1 ratings
Spotify
5.0 / 5
1 ratings
Podcast Authority Score: 9 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
18
Social presence
0
YouTube
0
Engagement
0
Contact What Pharma Needs Next
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of What Pharma Needs Next?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
